LIXT — Lixte Biotechnology Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- $17.23m
- $14.44m
Annual cashflow statement for Lixte Biotechnology Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.26 | -6.73 | -6.31 | -5.09 | -3.59 |
| Non-Cash Items | 1.25 | 2.6 | 1.55 | 0.773 | 0.418 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.118 | -0.013 | 0.155 | 0.021 | 0.003 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -2.13 | -4.14 | -4.61 | -4.29 | -3.16 |
| Financing Cash Flow Items | — | -0.01 | 0 | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 4.6 | 3.9 | 5.14 | 3.14 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2.47 | -0.246 | 0.53 | -1.15 | -3.16 |